Liquidia | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Court Finds United Therapeutics Breached Settlement Agreement by Restricting Distribution of Cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension

Business

18 Sep, 2024

Court Finds United Therapeutics Breached Settlement Agreement by Restricting Distribution of Cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension


Liquidia Corporation, a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today that the United States...

Liquidia Corporation to Present at Upcoming Investor Conferences in September 2024

Business

30 Aug, 2024

Liquidia Corporation to Present at Upcoming Investor Conferences in September 2024


Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, has announced its participation...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates